Lexaria Bioscience Corp. — Director's Dealing 2009

Jul 10, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2009-07-08

Reporting Person: Bhullar Baljinder (Director, Director/CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-07-10	Common Shares	P	40000	$0.05	Acquired	41250	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-07-10	Warrants	$0.2	P	40000	Acquired	2011-07-10	Common Shares (40000)	Direct
2009-07-08	Stock Options	$0.2	P	37500	Acquired	2011-07-20	Common Shares (37500)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.2	2011-07-20	Common Shares (12500)	12500	Direct

Footnotes

F1: On July 8, 2009, the exercise price was changed from $0.12